Case-control study of gadodiamide-related nephrogenic systemic fibrosis.

@article{Marckmann2007CasecontrolSO,
  title={Case-control study of gadodiamide-related nephrogenic systemic fibrosis.},
  author={Peter Marckmann and Lone Skov and Kristian Rossen and James Goya Heaf and Henrik S Thomsen},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2007},
  volume={22 11},
  pages={
          3174-8
        }
}
BACKGROUND Nephrogenic systemic fibrosis may be caused by gadolinium (Gd)-containing magnetic resonance imaging contrast agents. Most reported cases were associated with one particular agent, gadodiamide. Yet, unidentified cofactors might explain why only a minority of renal failure patients exposed to gadodiamide develop nephrogenic systemic fibrosis. METHODS We conducted a case-control study of 19 histologically verified cases and 19 sex- and age-matched controls. All subjects had chronic… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 76 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Similar Papers

Loading similar papers…